388 related articles for article (PubMed ID: 26424429)
21. Schizotypal traits and cognitive function in healthy adults.
Noguchi H; Hori H; Kunugi H
Psychiatry Res; 2008 Nov; 161(2):162-9. PubMed ID: 18849081
[TBL] [Abstract][Full Text] [Related]
22. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
23. Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study.
Jaeger S; Pfiffner C; Weiser P; Kilian R; Becker T; Längle G; Eschweiler GW; Croissant D; Schepp W; Steinert T
Psychiatry Res; 2012 Dec; 200(2-3):83-8. PubMed ID: 22534500
[TBL] [Abstract][Full Text] [Related]
24. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.
Jeste SD; Patterson TL; Palmer BW; Dolder CR; Goldman S; Jeste DV
Schizophr Res; 2003 Sep; 63(1-2):49-58. PubMed ID: 12892857
[TBL] [Abstract][Full Text] [Related]
25. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
Polgár P
Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
[TBL] [Abstract][Full Text] [Related]
26. Neuropsychological differences between schizophrenic patients with heterogeneous Wisconsin Card Sorting Test performance.
Goldstein G; Beers SR; Shemansky WJ
Schizophr Res; 1996 Jul; 21(1):13-8. PubMed ID: 8998271
[TBL] [Abstract][Full Text] [Related]
27. Affect recognition in schizophrenia: a function of global impairment or a specific cognitive deficit.
Bryson G; Bell M; Lysaker P
Psychiatry Res; 1997 Jul; 71(2):105-13. PubMed ID: 9255855
[TBL] [Abstract][Full Text] [Related]
28. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction.
Kawai N; Yamakawa Y; Baba A; Nemoto K; Tachikawa H; Hori T; Asada T; Iidaka T
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1009-14. PubMed ID: 16644082
[TBL] [Abstract][Full Text] [Related]
29. Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study.
Yi Z; Fan X; Wang J; Liu D; Freudenreich O; Goff D; Henderson DC
Psychiatry Res; 2012 Dec; 200(2-3):79-82. PubMed ID: 22727707
[TBL] [Abstract][Full Text] [Related]
30. Cognitive functioning related to quality of life in schizophrenia.
Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
[TBL] [Abstract][Full Text] [Related]
31. Performance of patients with schizophrenia on the Wisconsin Card Sorting Test (WCST).
Everett J; Lavoie K; Gagnon JF; Gosselin N
J Psychiatry Neurosci; 2001 Mar; 26(2):123-30. PubMed ID: 11291529
[TBL] [Abstract][Full Text] [Related]
32. [Recognition of facial emotions and theory of mind in schizophrenia: could the theory of mind deficit be due to the non-recognition of facial emotions?].
Besche-Richard C; Bourrin-Tisseron A; Olivier M; Cuervo-Lombard CV; Limosin F
Encephale; 2012 Jun; 38(3):241-7. PubMed ID: 22726412
[TBL] [Abstract][Full Text] [Related]
33. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
34. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
[TBL] [Abstract][Full Text] [Related]
35. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
36. Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study.
Husa AP; Rannikko I; Moilanen J; Haapea M; Murray GK; Barnett J; Jones PB; Isohanni M; Koponen H; Miettunen J; Jääskeläinen E
Schizophr Res; 2014 Sep; 158(1-3):134-41. PubMed ID: 25034761
[TBL] [Abstract][Full Text] [Related]
37. Visual versus Verbal Working Memory in Statistically Determined Patients with Mild Cognitive Impairment: On behalf of the Consortium for Clinical and Epidemiological Neuropsychological Data Analysis (CENDA).
Emrani S; Wasserman V; Matusz E; Miller D; Lamar M; Price CC; Ginsberg TB; Au R; Swenson R; Libon DJ
J Int Neuropsychol Soc; 2019 Nov; 25(10):1001-1010. PubMed ID: 31543085
[TBL] [Abstract][Full Text] [Related]
38. Clinical and cognitive correlates of insight in first-episode schizophrenia.
Chan SK; Chan KK; Lam MM; Chiu CP; Hui CL; Wong GH; Chang WC; Chen EY
Schizophr Res; 2012 Mar; 135(1-3):40-5. PubMed ID: 22245186
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia.
Gold S; Arndt S; Nopoulos P; O'Leary DS; Andreasen NC
Am J Psychiatry; 1999 Sep; 156(9):1342-8. PubMed ID: 10484943
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
